Vivesto AB (LON:0N4A)
London · Delayed Price · Currency is GBP · Price in SEK 0.0912
+0.0041 (4.71%)
Feb 12, 2026, 10:29 AM GMT
Vivesto AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
4.24M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 6.61M | 3.57M | 117.50% |
| Dec 31, 2022 | 3.04M | -25.83M | -89.47% |
| Dec 31, 2021 | 28.87M | 24.90M | 626.79% |
| Dec 31, 2020 | 3.97M | -202.23M | -98.07% |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Surgical Innovations Group | 11.92M |
| Cambridge Nutritional Sciences | 8.06M |
| Proteome Sciences | 4.53M |
| Feedback | 885.62K |